Key result
Multifactorial primary prevention of cardiovascular diseases has yielded disappointing long-term mortality results despite significant in-trial improvements in risk factor levels.
Why the study?
Multifactorial primary prevention trials have shown inconsistent in-trial prevention and diminished long-term benefits on risk factors and mortality, raising concerns about treatment effects.
Does multifactorial primary prevention reduce long-term total and coronary mortality in patients at risk for cardiovascular diseases?
Does multifactorial primary prevention reduce long-term total and coronary mortality in patients at risk for cardiovascular diseases?
Answers are grounded in this paper and cite their sources.
Multifactorial primary prevention trials have shown disappointing long-term mortality outcomes, highlighting the need to carefully select pharmacological interventions to ensure benefit outweighs harm.
Multifactorial primary prevention trials for reduction of cardiovascular diseases have engendered disappointing results because beneficial in-trial prevention has not been obtained consistently even when risk factor levels have been significantly improved. In addition, long term follow up studies, including post-trial periods, have revealed diminished or disappeared differences in risk factor levels between treated and control groups; total and coronary mortality differences have also been reduced or the death rates have even been increased during the post-trial period of treated group over those of control subjects in a study with a consistent coronary risk reduction during the intervention period. Reasons for this enhanced coronary mortality cannot be pointed out but drug treatment, especially beta-blocking agents in mild hypertension, should be studied more carefully. Despite this discouraging mortality finding multifactorial prevention with simultaneous reduction of several coronary risk factors sounds useful provided that pharmacological prevention could be selected to give more benefit than harm.
No takes yet. Share an insight, caveat, or question.
Miettinen et al. (1992) conducted a review in Cardiovascular diseases. Multifactorial primary prevention was evaluated on Total and coronary mortality. Multifactorial primary prevention of cardiovascular diseases has yielded disappointing long-term mortality results despite significant in-trial improvements in risk factor levels.
Synapse has enriched 10 related papers. Consider them for comparative context: